
Sign up to save your podcasts
Or


What if targeting a single cellular pathway could slow aging and boost immunity?
Dr. Joan Mannick, a leading voice in aging science, reveals how mTOR inhibitors may be the future of longevity therapeutics. From her early inspiration to groundbreaking clinical trials, Dr. Mannick explores the role of mTOR in aging, immune response, and antiviral immunity. Learn how selective mTOR inhibition could extend healthspan without compromising muscle mass, improve vaccine response in older adults, and unlock new possibilities in clinical longevity.
Learn more about Dr. Joan Mannick:
https://www.linkedin.com/in/joan-mannick-8089a614/
-
Download Dr. Buck Joffrey's FREE ebook, Living Longer for Busy People: https://ru01tne2.pages.infusionsoft.net/?affiliate=0
Book a FREE longevity coaching consultation with Dr. Buck Joffrey: https://coaching.longevityroadmap.com/
By Buck Joffrey5
3939 ratings
What if targeting a single cellular pathway could slow aging and boost immunity?
Dr. Joan Mannick, a leading voice in aging science, reveals how mTOR inhibitors may be the future of longevity therapeutics. From her early inspiration to groundbreaking clinical trials, Dr. Mannick explores the role of mTOR in aging, immune response, and antiviral immunity. Learn how selective mTOR inhibition could extend healthspan without compromising muscle mass, improve vaccine response in older adults, and unlock new possibilities in clinical longevity.
Learn more about Dr. Joan Mannick:
https://www.linkedin.com/in/joan-mannick-8089a614/
-
Download Dr. Buck Joffrey's FREE ebook, Living Longer for Busy People: https://ru01tne2.pages.infusionsoft.net/?affiliate=0
Book a FREE longevity coaching consultation with Dr. Buck Joffrey: https://coaching.longevityroadmap.com/

2,494 Listeners

3,847 Listeners

567 Listeners

7,216 Listeners

1,542 Listeners

402 Listeners

426 Listeners

8,876 Listeners

1,733 Listeners

9,194 Listeners

8,043 Listeners

723 Listeners

1,026 Listeners

29,272 Listeners

245 Listeners